We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Prof. Sebastian Kobold

Prof. Sebastian Kobold

Head of the Immunopharmacology Group and Deputy Director, Division of Clinical Pharmacology

 at University Hospital of Munich

Prof. Dr. med. Sebastian Kobold is professor for experimental immunooncology, head of the immunopharmacology group and deputy director of the division of clinical pharmacology at the university hospital in Munich. He has received, among many other awards, the Cancer Research Award 2022 of the Berlin-Brandenburg Academy of Sciences and the Georges Köhler Award 2023 of the German Society of Immunology. Focusing on tumor immunology, Prof. Kobold is especially interested in developing and testing novel strategies to treat cancer using the immune system. His goal is to translate his findings into the clinics in order to improve therapies for cancer patients.

Got a question for Prof. Sebastian Kobold?

Get in touch using the contact form linked here and we’ll get back to you shortly